| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hong Kong | 22 | 2021 | 3361 | 1.59 | Why? |
| Acinetobacter Infections | 2 | 2021 | 273 | 1.25 | Why? |
| Acinetobacter baumannii | 2 | 2021 | 378 | 1.23 | Why? |
| Cross Infection | 12 | 2021 | 8675 | 1.10 | Why? |
| Air Ionization | 1 | 2020 | 5 | 0.87 | Why? |
| Equipment Contamination | 3 | 2018 | 1308 | 0.79 | Why? |
| Hand Hygiene | 2 | 2020 | 1493 | 0.73 | Why? |
| Rheumatic Heart Disease | 1 | 2018 | 44 | 0.71 | Why? |
| Bacillaceae Infections | 1 | 2017 | 4 | 0.71 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 3 | 2019 | 711 | 0.69 | Why? |
| Encephalitis Virus, Japanese | 1 | 2018 | 63 | 0.69 | Why? |
| Bacillus | 1 | 2017 | 32 | 0.69 | Why? |
| Airports | 1 | 2020 | 284 | 0.68 | Why? |
| Encephalitis, Japanese | 1 | 2018 | 58 | 0.68 | Why? |
| Bedding and Linens | 1 | 2017 | 53 | 0.67 | Why? |
| Hand Disinfection | 2 | 2018 | 1671 | 0.66 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.64 | Why? |
| Carbapenems | 2 | 2018 | 343 | 0.62 | Why? |
| Caliciviridae Infections | 1 | 2019 | 229 | 0.62 | Why? |
| Environmental Microbiology | 2 | 2019 | 575 | 0.60 | Why? |
| Infection Control | 11 | 2021 | 23131 | 0.59 | Why? |
| Sewage | 1 | 2021 | 591 | 0.59 | Why? |
| Norovirus | 1 | 2019 | 294 | 0.59 | Why? |
| Severe Acute Respiratory Syndrome | 23 | 2020 | 12361 | 0.57 | Why? |
| Hydrogen Peroxide | 1 | 2020 | 680 | 0.56 | Why? |
| Hepacivirus | 3 | 2019 | 1509 | 0.55 | Why? |
| Liver Transplantation | 4 | 2019 | 2864 | 0.55 | Why? |
| beta-Lactam Resistance | 1 | 2016 | 150 | 0.55 | Why? |
| Disease Outbreaks | 12 | 2020 | 27595 | 0.55 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.51 | Why? |
| Drug Resistance, Multiple, Bacterial | 2 | 2021 | 1115 | 0.51 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.50 | Why? |
| Endocarditis | 1 | 2018 | 368 | 0.49 | Why? |
| Intensive Care Units, Neonatal | 1 | 2019 | 749 | 0.49 | Why? |
| Hand Sanitizers | 1 | 2018 | 397 | 0.46 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.42 | Why? |
| Hepatitis C | 2 | 2018 | 1514 | 0.40 | Why? |
| Enterobacteriaceae Infections | 1 | 2016 | 529 | 0.40 | Why? |
| Klebsiella pneumoniae | 1 | 2016 | 658 | 0.40 | Why? |
| Patient Participation | 1 | 2017 | 829 | 0.39 | Why? |
| Air Microbiology | 1 | 2019 | 1322 | 0.38 | Why? |
| Granulomatous Mastitis | 2 | 2018 | 8 | 0.38 | Why? |
| Cestoda | 2 | 2019 | 9 | 0.38 | Why? |
| Nematoda | 2 | 2019 | 34 | 0.37 | Why? |
| Corynebacterium | 2 | 2018 | 47 | 0.37 | Why? |
| Anti-Bacterial Agents | 4 | 2021 | 10083 | 0.36 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.36 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.35 | Why? |
| Escherichia coli | 1 | 2016 | 1547 | 0.35 | Why? |
| Molecular Diagnostic Techniques | 6 | 2020 | 4239 | 0.34 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.34 | Why? |
| Immunocompetence | 2 | 2008 | 280 | 0.33 | Why? |
| SARS Virus | 16 | 2020 | 13021 | 0.32 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.32 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.31 | Why? |
| Roseolovirus Infections | 2 | 2017 | 131 | 0.30 | Why? |
| Immunocompromised Host | 2 | 2019 | 5150 | 0.29 | Why? |
| Seasons | 2 | 2017 | 4071 | 0.29 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.28 | Why? |
| Herpesvirus 6, Human | 2 | 2017 | 162 | 0.28 | Why? |
| Saliva | 3 | 2019 | 4679 | 0.27 | Why? |
| Disease Transmission, Infectious | 2 | 2021 | 9044 | 0.27 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 449 | 0.26 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.25 | Why? |
| Real-Time Polymerase Chain Reaction | 8 | 2021 | 11367 | 0.24 | Why? |
| Microbial Sensitivity Tests | 3 | 2021 | 2886 | 0.24 | Why? |
| Travel-Related Illness | 2 | 2021 | 1357 | 0.22 | Why? |
| Coronavirus Infections | 16 | 2020 | 253789 | 0.20 | Why? |
| Nematode Infections | 1 | 2019 | 5 | 0.20 | Why? |
| Trematoda | 1 | 2019 | 8 | 0.20 | Why? |
| Cestode Infections | 1 | 2019 | 10 | 0.20 | Why? |
| Trematode Infections | 1 | 2019 | 9 | 0.20 | Why? |
| Steroids | 2 | 2004 | 904 | 0.19 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.19 | Why? |
| Humans | 68 | 2021 | 930598 | 0.19 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.19 | Why? |
| Communicable Diseases, Emerging | 2 | 2017 | 2523 | 0.18 | Why? |
| Corynebacterium Infections | 1 | 2018 | 26 | 0.18 | Why? |
| Contact Tracing | 1 | 2018 | 8448 | 0.18 | Why? |
| Sequence Analysis, DNA | 6 | 2018 | 2830 | 0.18 | Why? |
| Electron Transport Complex IV | 1 | 2017 | 21 | 0.18 | Why? |
| Acinetobacter | 1 | 2018 | 58 | 0.18 | Why? |
| Coronavirus | 7 | 2020 | 18339 | 0.18 | Why? |
| Haemophilus | 1 | 2017 | 13 | 0.18 | Why? |
| Laundry Service, Hospital | 1 | 2017 | 10 | 0.18 | Why? |
| Respiratory Tract Infections | 5 | 2019 | 6817 | 0.17 | Why? |
| Bacterial Typing Techniques | 1 | 2019 | 273 | 0.17 | Why? |
| Adenoviridae Infections | 1 | 2018 | 150 | 0.17 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 2984 | 0.17 | Why? |
| Haemophilus Infections | 1 | 2017 | 69 | 0.17 | Why? |
| Viral Load | 9 | 2019 | 15850 | 0.16 | Why? |
| Adenoviruses, Human | 1 | 2018 | 195 | 0.16 | Why? |
| Haemophilus influenzae | 1 | 2017 | 196 | 0.16 | Why? |
| Microbial Viability | 1 | 2020 | 406 | 0.16 | Why? |
| Enterovirus D, Human | 1 | 2017 | 96 | 0.16 | Why? |
| Porins | 1 | 2016 | 45 | 0.15 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.15 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.15 | Why? |
| Medical Records | 1 | 2018 | 513 | 0.15 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.15 | Why? |
| Coronavirus 229E, Human | 5 | 2009 | 1241 | 0.14 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2021 | 13720 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2018 | 306 | 0.14 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.14 | Why? |
| Genes, Bacterial | 1 | 2016 | 207 | 0.14 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.14 | Why? |
| Phylogeny | 7 | 2018 | 13341 | 0.14 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.13 | Why? |
| Male | 30 | 2021 | 367725 | 0.13 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.13 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2019 | 1439 | 0.13 | Why? |
| Fatal Outcome | 3 | 2019 | 3438 | 0.13 | Why? |
| Recombination, Genetic | 2 | 2018 | 1265 | 0.13 | Why? |
| Virulence | 1 | 2020 | 2172 | 0.12 | Why? |
| Polymerase Chain Reaction | 3 | 2018 | 6740 | 0.12 | Why? |
| Enterovirus Infections | 1 | 2017 | 404 | 0.12 | Why? |
| Fomites | 1 | 2018 | 709 | 0.12 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.12 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.11 | Why? |
| Nasopharynx | 8 | 2018 | 10224 | 0.11 | Why? |
| Diarrhea | 1 | 2004 | 2743 | 0.11 | Why? |
| Influenza in Birds | 1 | 2017 | 528 | 0.11 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.11 | Why? |
| Transcription, Genetic | 2 | 2009 | 1326 | 0.11 | Why? |
| Female | 26 | 2021 | 380317 | 0.11 | Why? |
| Whole Genome Sequencing | 2 | 2019 | 3239 | 0.11 | Why? |
| Virus Inactivation | 1 | 2020 | 1139 | 0.11 | Why? |
| Aged, 80 and over | 12 | 2020 | 88759 | 0.10 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.10 | Why? |
| Virus Diseases | 2 | 2019 | 3779 | 0.10 | Why? |
| Dermatomycoses | 1 | 2010 | 55 | 0.10 | Why? |
| Drug Therapy | 1 | 2012 | 280 | 0.10 | Why? |
| beta-Lactamases | 1 | 2016 | 759 | 0.10 | Why? |
| Mucorales | 1 | 2010 | 92 | 0.09 | Why? |
| Plasma | 1 | 2019 | 1809 | 0.09 | Why? |
| Adult | 23 | 2021 | 244371 | 0.09 | Why? |
| Coronavirus OC43, Human | 3 | 2006 | 1157 | 0.09 | Why? |
| Aged | 19 | 2020 | 215776 | 0.09 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.09 | Why? |
| DNA, Ribosomal | 2 | 2019 | 112 | 0.09 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.09 | Why? |
| Middle East | 1 | 2013 | 1418 | 0.09 | Why? |
| Infectious Mononucleosis | 1 | 2008 | 35 | 0.09 | Why? |
| Middle Aged | 21 | 2020 | 270681 | 0.09 | Why? |
| Nose Diseases | 1 | 2010 | 139 | 0.09 | Why? |
| Homes for the Aged | 1 | 2018 | 1071 | 0.09 | Why? |
| Immune Sera | 1 | 2012 | 884 | 0.08 | Why? |
| Pyrimidinones | 2 | 2004 | 76 | 0.08 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.08 | Why? |
| Bacterial Proteins | 1 | 2016 | 1318 | 0.08 | Why? |
| Guinea Pigs | 1 | 2007 | 420 | 0.08 | Why? |
| Viruses | 2 | 2019 | 2238 | 0.08 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.08 | Why? |
| Metapneumovirus | 1 | 2008 | 465 | 0.07 | Why? |
| Cystitis | 1 | 2005 | 45 | 0.07 | Why? |
| Bacteria | 1 | 2016 | 1897 | 0.07 | Why? |
| Paramyxoviridae Infections | 1 | 2008 | 364 | 0.07 | Why? |
| Point-of-Care Testing | 1 | 2018 | 2782 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| China | 6 | 2020 | 50654 | 0.07 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Phenotype | 1 | 2016 | 4037 | 0.07 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.07 | Why? |
| Respiratory System | 1 | 2017 | 3213 | 0.07 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.07 | Why? |
| BK Virus | 1 | 2005 | 135 | 0.07 | Why? |
| Antigens, Viral | 3 | 2006 | 6298 | 0.07 | Why? |
| Polyomavirus Infections | 1 | 2005 | 156 | 0.06 | Why? |
| Sensitivity and Specificity | 8 | 2019 | 22971 | 0.06 | Why? |
| Base Sequence | 3 | 2019 | 3581 | 0.06 | Why? |
| Risk Factors | 5 | 2019 | 71621 | 0.06 | Why? |
| Bacterial Infections | 1 | 2016 | 2229 | 0.06 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.05 | Why? |
| Antiviral Agents | 5 | 2018 | 41703 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.05 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.05 | Why? |
| Zoonoses | 1 | 2015 | 3034 | 0.05 | Why? |
| Cats | 1 | 2007 | 1890 | 0.05 | Why? |
| Nucleocapsid Proteins | 4 | 2005 | 3120 | 0.05 | Why? |
| Mucormycosis | 1 | 2010 | 832 | 0.05 | Why? |
| HIV Protease Inhibitors | 1 | 2004 | 434 | 0.05 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2019 | 7218 | 0.05 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
| DNA, Protozoan | 1 | 2019 | 77 | 0.05 | Why? |
| Nucleocapsid | 1 | 2004 | 734 | 0.05 | Why? |
| Common Cold | 1 | 2005 | 645 | 0.05 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.05 | Why? |
| Interior Design and Furnishings | 1 | 2018 | 33 | 0.05 | Why? |
| Animals | 9 | 2019 | 78931 | 0.05 | Why? |
| Genome, Viral | 2 | 2018 | 13157 | 0.05 | Why? |
| RNA, Viral | 5 | 2021 | 32276 | 0.05 | Why? |
| DNA, Helminth | 1 | 2017 | 15 | 0.04 | Why? |
| Immunotherapy | 1 | 2012 | 2421 | 0.04 | Why? |
| Beds | 1 | 2018 | 79 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.04 | Why? |
| Brain Diseases | 1 | 2010 | 1463 | 0.04 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.04 | Why? |
| Bathroom Equipment | 1 | 2018 | 107 | 0.04 | Why? |
| Reagent Kits, Diagnostic | 2 | 2018 | 2149 | 0.04 | Why? |
| Microarray Analysis | 2 | 2009 | 262 | 0.04 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2005 | 7868 | 0.04 | Why? |
| Cross Reactions | 3 | 2018 | 4374 | 0.04 | Why? |
| Gastrointestinal Diseases | 1 | 2010 | 2580 | 0.03 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2015 | 10998 | 0.03 | Why? |
| DNA Primers | 1 | 2019 | 1170 | 0.03 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.03 | Why? |
| Respiratory Syncytial Viruses | 1 | 2018 | 612 | 0.03 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
| Drug Therapy, Combination | 2 | 2004 | 7268 | 0.03 | Why? |
| Patients' Rooms | 1 | 2018 | 675 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 492 | 0.03 | Why? |
| Feces | 3 | 2019 | 4235 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2015 | 8843 | 0.03 | Why? |
| Community-Acquired Infections | 1 | 2005 | 2328 | 0.03 | Why? |
| Sequence Alignment | 1 | 2019 | 2109 | 0.03 | Why? |
| Influenza B virus | 1 | 2018 | 815 | 0.03 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.03 | Why? |
| Open Reading Frames | 1 | 2018 | 1898 | 0.03 | Why? |
| Poultry Diseases | 1 | 2017 | 588 | 0.03 | Why? |
| Chickens | 1 | 2017 | 1010 | 0.03 | Why? |
| Sheep | 1 | 2012 | 420 | 0.03 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2005 | 2426 | 0.03 | Why? |
| Rats | 1 | 2018 | 2764 | 0.03 | Why? |
| Hospitals, Public | 1 | 2017 | 774 | 0.03 | Why? |
| Genes, Fungal | 1 | 2010 | 21 | 0.03 | Why? |
| Molecular Sequence Data | 2 | 2006 | 3198 | 0.03 | Why? |
| Ritonavir | 1 | 2004 | 4212 | 0.02 | Why? |
| Cell Line, Tumor | 2 | 2009 | 3608 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.02 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.02 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.02 | Why? |
| Genes, pol | 1 | 2005 | 38 | 0.02 | Why? |
| Seizures, Febrile | 1 | 2006 | 59 | 0.02 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.02 | Why? |
| Genes | 1 | 2005 | 50 | 0.02 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.02 | Why? |
| Viverridae | 1 | 2006 | 225 | 0.02 | Why? |
| Membrane Glycoproteins | 2 | 2005 | 2273 | 0.02 | Why? |
| Rimantadine | 1 | 2004 | 13 | 0.02 | Why? |
| Chlorogenic Acid | 1 | 2004 | 25 | 0.02 | Why? |
| Child, Preschool | 3 | 2017 | 36283 | 0.02 | Why? |
| Software | 1 | 2017 | 2501 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2004 | 8041 | 0.02 | Why? |
| Ofloxacin | 1 | 2003 | 23 | 0.02 | Why? |
| Transplantation, Autologous | 1 | 2005 | 364 | 0.02 | Why? |
| Retrospective Studies | 4 | 2018 | 105322 | 0.02 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2003 | 72 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Pulse Therapy, Drug | 1 | 2003 | 137 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Fluorescent Antibody Technique | 1 | 2005 | 835 | 0.02 | Why? |
| Viral Plaque Assay | 1 | 2004 | 381 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.01 | Why? |
| Virus Replication | 1 | 2004 | 14331 | 0.01 | Why? |
| Viral Envelope Proteins | 2 | 2005 | 3539 | 0.01 | Why? |
| Urine | 1 | 2005 | 469 | 0.01 | Why? |
| Glycyrrhizic Acid | 1 | 2004 | 190 | 0.01 | Why? |
| Confidence Intervals | 1 | 2005 | 744 | 0.01 | Why? |
| Saudi Arabia | 1 | 2012 | 4423 | 0.01 | Why? |
| Blotting, Western | 1 | 2004 | 863 | 0.01 | Why? |
| Interferon beta-1a | 1 | 2004 | 316 | 0.01 | Why? |
| Nursing Homes | 1 | 2018 | 4155 | 0.01 | Why? |
| Drug Synergism | 1 | 2004 | 833 | 0.01 | Why? |
| Probability | 1 | 2005 | 923 | 0.01 | Why? |
| Rabbits | 1 | 2004 | 1171 | 0.01 | Why? |
| Microscopy, Electron | 1 | 2003 | 830 | 0.01 | Why? |
| Virus Activation | 1 | 2005 | 480 | 0.01 | Why? |
| Antibodies, Viral | 4 | 2005 | 51949 | 0.01 | Why? |
| Child | 3 | 2017 | 70012 | 0.01 | Why? |
| Disease Progression | 3 | 2004 | 13580 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Molecular Epidemiology | 1 | 2005 | 1638 | 0.01 | Why? |
| Flavonoids | 1 | 2004 | 492 | 0.01 | Why? |
| Virus Cultivation | 1 | 2003 | 579 | 0.01 | Why? |
| Lopinavir | 2 | 2004 | 4308 | 0.01 | Why? |
| World Health Organization | 1 | 2012 | 4213 | 0.01 | Why? |
| Hospitalization | 3 | 2019 | 54280 | 0.01 | Why? |
| Coinfection | 1 | 2019 | 6820 | 0.01 | Why? |
| Infusions, Intravenous | 1 | 2003 | 1224 | 0.01 | Why? |
| Infant | 2 | 2016 | 30274 | 0.01 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.01 | Why? |
| Interferon-beta | 1 | 2004 | 979 | 0.01 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.01 | Why? |
| Chiroptera | 1 | 2012 | 3530 | 0.01 | Why? |
| Ribavirin | 1 | 2004 | 1182 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2009 | 4020 | 0.01 | Why? |
| Opportunistic Infections | 1 | 2003 | 602 | 0.01 | Why? |
| Interferon-alpha | 1 | 2004 | 1442 | 0.01 | Why? |
| Administration, Oral | 1 | 2003 | 2340 | 0.01 | Why? |
| Radiography | 1 | 2003 | 1576 | 0.01 | Why? |
| Apoptosis | 1 | 2005 | 2335 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2004 | 3786 | 0.01 | Why? |
| Acute Disease | 1 | 2006 | 6029 | 0.01 | Why? |
| Odds Ratio | 1 | 2004 | 5861 | 0.01 | Why? |
| Proportional Hazards Models | 1 | 2004 | 6543 | 0.01 | Why? |
| Serologic Tests | 1 | 2006 | 4359 | 0.01 | Why? |
| Survival Analysis | 1 | 2004 | 7592 | 0.01 | Why? |
| RNA, Messenger | 1 | 2005 | 5131 | 0.01 | Why? |
| Immunoglobulin G | 2 | 2005 | 21571 | 0.01 | Why? |
| Blood Donors | 1 | 2004 | 2956 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2010 | 5397 | 0.01 | Why? |
| Cell Line | 1 | 2004 | 12040 | 0.01 | Why? |
| Survival Rate | 1 | 2003 | 9206 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2004 | 10017 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2005 | 9091 | 0.01 | Why? |
| Viral Proteins | 1 | 2006 | 7370 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2006 | 48226 | 0.01 | Why? |
| Length of Stay | 1 | 2003 | 11042 | 0.00 | Why? |
| Follow-Up Studies | 1 | 2003 | 17020 | 0.00 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2005 | 37182 | 0.00 | Why? |
| Incidence | 1 | 2006 | 25622 | 0.00 | Why? |
| Age Factors | 1 | 2004 | 21039 | 0.00 | Why? |
| Prognosis | 1 | 2005 | 32490 | 0.00 | Why? |
| Pregnancy | 1 | 2003 | 23879 | 0.00 | Why? |
| Risk Assessment | 1 | 2005 | 25439 | 0.00 | Why? |
| Pregnancy Complications, Infectious | 1 | 2003 | 11559 | 0.00 | Why? |
| Lung | 1 | 2003 | 31049 | 0.00 | Why? |